Guanfacine and secondary mania in children
Related Experiment Videos
1Division of Child Psychiatry, UNC Hospitals, Chapel Hill 27599-7160, USA. jhorrigan@css.unc.edu
Introduction:
Guanfacine hydrochloride is an alpha-2 adrenergic agonist, which has gained recent attention in the field of child and adolescent psychiatry. This medication has been described as effective in the management of attention-deficit hyperactivity and tic disorders, with minimal side effects.
Methods:
Presented here are five cases of behavioral activation in children treated with guanfacine.
Results:
In each instance the clinical presentation resembled an acute hypomanic or manic episode. The dose of guanfacine was 0.5 mg/day. Later investigation revealed that all of the youngsters had clear risk factors (clinical and/or familial) for bipolar disorder.
Conclusions:
It appears as though guanfacine may be capable of precipitating secondary mania in vulnerable children.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Bipolar Disorder
Psychosis: Goals of Pharmacotherapy